Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-4_18-cv-05769/USCOURTS-cand-4_18-cv-05769-1/pdf.json

Nature of Suit Code: 830
Nature of Suit: Patent
Cause of Action: 35:271 Patent Infringement

---

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

United States District Court

Northern District of California

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

FLOW PHARMA, INC.,

Plaintiff,

v.

BAUSCH HEALTH COMPANIES INC., et 

al.,

Defendants.

Case No. 18-cv-05769-JST (AGT)

ORDER REQUESTING 

SUPPLEMENTAL SUBMISSION

Re: Dkt. Nos. 65, 72

In the parties’ most recent joint statement, Flow Pharma explained that by April 28 it 

would provide Bausch with a third supplemental response to Interrogatory No. 10. See ECF No. 

72 at 4. By tomorrow, May 7, Flow Pharma must file a copy of that third supplemental response

with the Court. No argument should be included with the filing. 

IT IS SO ORDERED.

Dated: May 6, 2020

ALEX G. TSE

United States Magistrate Judge

Case 4:18-cv-05769-JST Document 75 Filed 05/08/20 Page 1 of 1